<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2015-17-144-148</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-441</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Практика</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Practice</subject></subj-group></article-categories><title-group><article-title>Ожирение как фактор риска нарушения обмена железа</article-title><trans-title-group xml:lang="en"><trans-title>Obesity is a risk factor for iron metabolism disorder</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дворецкий</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Dvoretskiy</surname><given-names>L. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ивлева</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivleva</surname><given-names>O. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Первый Московский государственный медицинский университет им. И.М. Сеченова<country>Россия</country></aff><aff xml:lang="en">First Moscow State Medical University named after I.M. Sechenov<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2015</year></pub-date><volume>0</volume><issue>17</issue><fpage>144</fpage><lpage>148</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Дворецкий Л.И., Ивлева О.В., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Дворецкий Л.И., Ивлева О.В.</copyright-holder><copyright-holder xml:lang="en">Dvoretskiy L.I., Ivleva O.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/441">https://www.med-sovet.pro/jour/article/view/441</self-uri><abstract><p>Приводятся данные о патогенетической связи между железодефицитом и наличием системного воспаления, ассоциированного с ожирением. В условиях хронического воспаления при ожирении запускается механизм секвестрации железа, преимущественно клетками макрофагальной системы и жировой ткани, снижается эффективность усвоения железа из пищи, поступление его в эритроидные клетки и синтез гема. Избыточно накопленное в клетках жировой ткани железо индуцирует оксида-тивный и эндоплазматический стресс, выработку провоспалительных цитокинов, т. е. воздействует на основные звенья патогенеза ожирения и усугубляет его. Имеются клинические данные об улучшении показателей обмена железа и снижении уровня сывороточного гепсидина у больных при снижении веса после бариатрических операций. Данные о частоте и патогенетическом варианте анемии (железодефицитная или анемия хронических заболеваний) после бариатрических операций неоднозначны.</p></abstract><trans-abstract xml:lang="en"><p>There is data on the pathogenetic links between iron deficiency and systemic inflammation associated with obesity. In chronic inflammation in obese patients, a mechanism of iron sequestration becomes activated primarily by macrophage and adipose tissue cells. The efficiency of iron absorption from food, its uptake by erythroid cells and heme synthesis are decreased. Excessive accumulation of iron in fat cells induces oxidative and endoplasmic stress and production of proinflammatory cytokines, thus affecting the key pathogenetic links of obesity and exacerbating the condition. There is clinical evidence suggesting better iron metabolism parameters and decreased serum hepcidin in patients who lost weight after bariatric surgery. The findings related to the incidence and pathogenic form of anemia (iron deficiency or anemia of chronic disease) after bariatric surgery are heterogenous.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ожирение</kwd><kwd>дефицит железа</kwd><kwd>ферритин</kwd><kwd>хроническое воспаление</kwd><kwd>гепсидин</kwd><kwd>анемия</kwd><kwd>бариатрические операции</kwd><kwd>obesity</kwd><kwd>iron deficiency</kwd><kwd>ferritin</kwd><kwd>chronic inflammation</kwd><kwd>hepcidin</kwd><kwd>anemia</kwd><kwd>bariatric surgery</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization (WHO), Fact Sheet No.311 (May 2012) available at: http//www. who.int/mediacentre/factsheets/fs311/en/</mixed-citation><mixed-citation xml:lang="en">World Health Organization (WHO), Fact Sheet No.311 (May 2012) available at: http//www. who.int/mediacentre/factsheets/fs311/en/</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Fruhbeck G, Toplak H, Woodward E, Yumuk V, Maislos M, Oppert JM. Obesity: The gateway to ill health - an EASO Position Statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts, 2013. 6: 117-20.</mixed-citation><mixed-citation xml:lang="en">Fruhbeck G, Toplak H, Woodward E, Yumuk V, Maislos M, Oppert JM. Obesity: The gateway to ill health - an EASO Position Statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts, 2013. 6: 117-20.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Seltzer Carl C, Mayer J. Serum Iron and Iron-Binding Capacity in Adolescents. II. Comparison of Obese and Nonobese Subjects. Am J Clin Nutr, 1963, vol. 13, no. 6: 354-361</mixed-citation><mixed-citation xml:lang="en">Seltzer Carl C, Mayer J. Serum Iron and Iron-Binding Capacity in Adolescents. II. Comparison of Obese and Nonobese Subjects. Am J Clin Nutr, 1963, vol. 13, no. 6: 354-361</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Pinhas-Hamiel O, Newfield RS, Koren I, Agmon A, Luos P, Phillip M. Greater prevalence of iron defiency in overweiht and obese children and adolescents. Int J Obes Relat Metab. Disord., 2003. 27: 416-418.</mixed-citation><mixed-citation xml:lang="en">Pinhas-Hamiel O, Newfield RS, Koren I, Agmon A, Luos P, Phillip M. Greater prevalence of iron defiency in overweiht and obese children and adolescents. Int J Obes Relat Metab. Disord., 2003. 27: 416-418.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Wen M. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics. 2004. 114: 104-108.</mixed-citation><mixed-citation xml:lang="en">Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Wen M. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics. 2004. 114: 104-108.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lecube A, Carrera A, Losada E, Hernandez C. Simo R, Mesa J. Iron deficiency in obese post-menopausal women. Obesity, 2006. 14: 17241730.</mixed-citation><mixed-citation xml:lang="en">Lecube A, Carrera A, Losada E, Hernandez C. Simo R, Mesa J. Iron deficiency in obese post-menopausal women. Obesity, 2006. 14: 17241730.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">O'Broin S, Kelleher B, Balfe A, McMahon C. Evaluation of serum transferring receptor assay in a centralized iron screening service. Clin Lab Haem, 2005. 27: 190-194.</mixed-citation><mixed-citation xml:lang="en">O'Broin S, Kelleher B, Balfe A, McMahon C. Evaluation of serum transferring receptor assay in a centralized iron screening service. Clin Lab Haem, 2005. 27: 190-194.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wish B. Assessing iron status: beyond sarum ferritin and transferrin saturation. Clin J Am Soc Nephrol., 2006: 54-58.</mixed-citation><mixed-citation xml:lang="en">Wish B. Assessing iron status: beyond sarum ferritin and transferrin saturation. Clin J Am Soc Nephrol., 2006: 54-58.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Monzie CM, Yanoff LB, Oenkinger BI, 6t al. Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc, 2008. 108: 145-148.</mixed-citation><mixed-citation xml:lang="en">Monzie CM, Yanoff LB, Oenkinger BI, 6t al. Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc, 2008. 108: 145-148.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yanoff LB, Menzie CM, Denkinger B et at Innammation and iron deficiency in the hypo-ferremia of obesity. Int J Obes (Lond), 2007. 31: 1412-1419.</mixed-citation><mixed-citation xml:lang="en">Yanoff LB, Menzie CM, Denkinger B et at Innammation and iron deficiency in the hypo-ferremia of obesity. Int J Obes (Lond), 2007. 31: 1412-1419.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tajima S, Ikeda Y, Sawada K, Yamano N, Horinouchi Y, Kihira Y, Ishizawa K et al. Iron reduction by deferoxamine leads to melioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice. Am J Physiol Endocrinol Metab. 2012. 302: 77-8.</mixed-citation><mixed-citation xml:lang="en">Tajima S, Ikeda Y, Sawada K, Yamano N, Horinouchi Y, Kihira Y, Ishizawa K et al. Iron reduction by deferoxamine leads to melioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice. Am J Physiol Endocrinol Metab. 2012. 302: 77-8.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Tinkov AA, Polyakova VS, Nikonorov AA. Chronic administration of iron and copper potentiates adipogenic effect of high fat diet in albino Wistar rats. Biometals, 2013. 26(3): 447-463.</mixed-citation><mixed-citation xml:lang="en">Tinkov AA, Polyakova VS, Nikonorov AA. Chronic administration of iron and copper potentiates adipogenic effect of high fat diet in albino Wistar rats. Biometals, 2013. 26(3): 447-463.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Datz C, Felder, TK, Niederseer D, Aigner E. Iron homeostasis in the metabolic syndrome. Eur. J. Clin. Investig, 2013. 43: 215-224.</mixed-citation><mixed-citation xml:lang="en">Datz C, Felder, TK, Niederseer D, Aigner E. Iron homeostasis in the metabolic syndrome. Eur. J. Clin. Investig, 2013. 43: 215-224.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bertinato J, Aroche C, Plouffe LI, Lee M, Murtaza Z, Kenney L, Lavergne C, Aziz A. Diet-induced obese rats have higher iron requirements and are more vulnerable to iron deficiency. Eur J Nutr., 2013. 6.</mixed-citation><mixed-citation xml:lang="en">Bertinato J, Aroche C, Plouffe LI, Lee M, Murtaza Z, Kenney L, Lavergne C, Aziz A. Diet-induced obese rats have higher iron requirements and are more vulnerable to iron deficiency. Eur J Nutr., 2013. 6.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Chung B, Matak P, McKie AT, Sharp P. Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr., 2007. 37(11): 2366-70.</mixed-citation><mixed-citation xml:lang="en">Chung B, Matak P, McKie AT, Sharp P. Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr., 2007. 37(11): 2366-70.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Truksa J, Peng H, Lee P, Beutler E. Bone mor-phogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci U S A, 2006. 103(27): 10289-93.</mixed-citation><mixed-citation xml:lang="en">Truksa J, Peng H, Lee P, Beutler E. Bone mor-phogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci U S A, 2006. 103(27): 10289-93.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Collins JF, Wessling-Resnick M, Knutson MD. Hepcidin regulation of iron transport. J Nutr, 2008. 138(11): 2284-8.</mixed-citation><mixed-citation xml:lang="en">Collins JF, Wessling-Resnick M, Knutson MD. Hepcidin regulation of iron transport. J Nutr, 2008. 138(11): 2284-8.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben Amor I et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and nash. Gastroenterology, 2006. 131: 788-796.</mixed-citation><mixed-citation xml:lang="en">Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben Amor I et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and nash. Gastroenterology, 2006. 131: 788-796.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Coimbra S, Catarino C, Santos-Silva A. The role of adipocytes in the modulation of iron metabolism in obesity. Obes Rev., 2013. 14(10): 771-9.</mixed-citation><mixed-citation xml:lang="en">Coimbra S, Catarino C, Santos-Silva A. The role of adipocytes in the modulation of iron metabolism in obesity. Obes Rev., 2013. 14(10): 771-9.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Vuppalanchi R, Troutt JS, Konrad RJ, Ghabril M ,Saxena R, Bell LN, Kowdley KV, Chalasani N. Serum hepcidin levels are associated with obesity but not liver disease. Obesity (Silver Spring), 2013. 22(3): 836-41.</mixed-citation><mixed-citation xml:lang="en">Vuppalanchi R, Troutt JS, Konrad RJ, Ghabril M ,Saxena R, Bell LN, Kowdley KV, Chalasani N. Serum hepcidin levels are associated with obesity but not liver disease. Obesity (Silver Spring), 2013. 22(3): 836-41.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Zimmermann MB, Zeder C, Muthayya S, Winichagoon P. Chaouki N, Aeberli I, Hurrell RF. Adiposity in women and children from transition countries predicts decreased iron absorption, iron deficiency and a reduced response to iron fortification. Int. J. Obes., 2008. 32: 1098-1104.</mixed-citation><mixed-citation xml:lang="en">Zimmermann MB, Zeder C, Muthayya S, Winichagoon P. Chaouki N, Aeberli I, Hurrell RF. Adiposity in women and children from transition countries predicts decreased iron absorption, iron deficiency and a reduced response to iron fortification. Int. J. Obes., 2008. 32: 1098-1104.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Mujica-Coopman MF, Brito A, Lopez de Romana D, Pizarro F, Olivares M. Body mass index, iron absorption and iron status in childbearing age women. J. Trace Elem. Med. Biol., 2014.</mixed-citation><mixed-citation xml:lang="en">Mujica-Coopman MF, Brito A, Lopez de Romana D, Pizarro F, Olivares M. Body mass index, iron absorption and iron status in childbearing age women. J. Trace Elem. Med. Biol., 2014.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Rivera S, Liu L, Nemeth E, Gabayan V, Sorensen OE, Ganz T. Hepcidin excess induces the sequestration ofiron and exacerbates tumor-associated anemia. Blood, 2005. 105(4): 1797-802.</mixed-citation><mixed-citation xml:lang="en">Rivera S, Liu L, Nemeth E, Gabayan V, Sorensen OE, Ganz T. Hepcidin excess induces the sequestration ofiron and exacerbates tumor-associated anemia. Blood, 2005. 105(4): 1797-802.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Ganz T, Nemeth E. Iron sequestration and anemia of inflammation. Semin. Hematol., 2009. 46: 387-393.</mixed-citation><mixed-citation xml:lang="en">Ganz T, Nemeth E. Iron sequestration and anemia of inflammation. Semin. Hematol., 2009. 46: 387-393.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Tussing-Humphreys L, Pustacioglu C, Nemeth E, Braunschweig C. Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin. Jour of Acad of Nutr and Diet, 2012. 112: 391-400.</mixed-citation><mixed-citation xml:lang="en">Tussing-Humphreys L, Pustacioglu C, Nemeth E, Braunschweig C. Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin. Jour of Acad of Nutr and Diet, 2012. 112: 391-400.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Cani PD, Bibiloni R, Knauf C, Waget A et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes, 2008. 57(6): 1470-81.</mixed-citation><mixed-citation xml:lang="en">Cani PD, Bibiloni R, Knauf C, Waget A et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes, 2008. 57(6): 1470-81.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Yang J, Goetz D, Li JY, Wang W, Mori K et al. An iron delivery pathway mediated by a lipocalin. Mol Cell, 2002. 10(5): 1045-56.</mixed-citation><mixed-citation xml:lang="en">Yang J, Goetz D, Li JY, Wang W, Mori K et al. An iron delivery pathway mediated by a lipocalin. Mol Cell, 2002. 10(5): 1045-56.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao P, Stephens JM. STAT1, NF-kB and ERKs play a role in the induction of lipocalin-2 expression in adipocytes. Molecular Metabolism, 2013. 2(3): 161-170.</mixed-citation><mixed-citation xml:lang="en">Zhao P, Stephens JM. STAT1, NF-kB and ERKs play a role in the induction of lipocalin-2 expression in adipocytes. Molecular Metabolism, 2013. 2(3): 161-170.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Jomova K, Baros S, Valko M. Redox active met-alinduced oxidative stress in biological systems. Transition Metal Chemistry, 2012. 37(2): 127-134.</mixed-citation><mixed-citation xml:lang="en">Jomova K, Baros S, Valko M. Redox active met-alinduced oxidative stress in biological systems. Transition Metal Chemistry, 2012. 37(2): 127-134.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Couillard C, Ruel G, Archer WR, Pomerleau S et al. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab., 2005. 90(12): 6454-9.</mixed-citation><mixed-citation xml:lang="en">Couillard C, Ruel G, Archer WR, Pomerleau S et al. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab., 2005. 90(12): 6454-9.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuzawa-Nagata N, Takamura T, Ando H et al. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism, 2008. 57(8): 1071-7.</mixed-citation><mixed-citation xml:lang="en">Matsuzawa-Nagata N, Takamura T, Ando H et al. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism, 2008. 57(8): 1071-7.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Gregor MF, Yang L, Fabbrini E, Mohammed BS, Eagon JC, Hotamisligil GS, Klein S. Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes, 2009. 58(3): 693-700.</mixed-citation><mixed-citation xml:lang="en">Gregor MF, Yang L, Fabbrini E, Mohammed BS, Eagon JC, Hotamisligil GS, Klein S. Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes, 2009. 58(3): 693-700.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Tan TC, Crawford DH, Jaskowski LA et al. Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury. Lab Invest., 2013. 93(12): 1295-312.</mixed-citation><mixed-citation xml:lang="en">Tan TC, Crawford DH, Jaskowski LA et al. Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury. Lab Invest., 2013. 93(12): 1295-312.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Tzanavari T, Giannogonas P, Karalis KP. TNF-alpha and obesity. Curr Dir Autoimmun., 2010. 11: 145-56.</mixed-citation><mixed-citation xml:lang="en">Tzanavari T, Giannogonas P, Karalis KP. TNF-alpha and obesity. Curr Dir Autoimmun., 2010. 11: 145-56.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Zager RA, Johnson AC, Hanson SY, Lund S. Parenteral iron compounds sensitize mice to injury-initiated TNF-alpha mRNA production and TNF-alpha release. Am J Physiol Renal Physiol., 2005. 288(2): F290-7.</mixed-citation><mixed-citation xml:lang="en">Zager RA, Johnson AC, Hanson SY, Lund S. Parenteral iron compounds sensitize mice to injury-initiated TNF-alpha mRNA production and TNF-alpha release. Am J Physiol Renal Physiol., 2005. 288(2): F290-7.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Maury E, Nodl L, Detry R, Brichard SM. In vitro hyperresponsiveness to tumor necrosis factor-alpha contributes to adipokine dysregulation in omental adipocytes of obese subjects. J Clin Endocrinol Metab., 2009. 94(4): 1393-400.</mixed-citation><mixed-citation xml:lang="en">Maury E, Nodl L, Detry R, Brichard SM. In vitro hyperresponsiveness to tumor necrosis factor-alpha contributes to adipokine dysregulation in omental adipocytes of obese subjects. J Clin Endocrinol Metab., 2009. 94(4): 1393-400.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Sjostrom L. Review of the key results from the Swedish Obese Subject (SOS) trial-a prospective controlled intervention study of bariatric surgery. J Intern Med., 2013. 273: 219-34.</mixed-citation><mixed-citation xml:lang="en">Sjostrom L. Review of the key results from the Swedish Obese Subject (SOS) trial-a prospective controlled intervention study of bariatric surgery. J Intern Med., 2013. 273: 219-34.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Neovius M, Narbro K, Keating C et al. Health care use during 20 years following bariatric surgery. JAMA, 2012. 308: 1132-41.</mixed-citation><mixed-citation xml:lang="en">Neovius M, Narbro K, Keating C et al. Health care use during 20 years following bariatric surgery. JAMA, 2012. 308: 1132-41.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Fried M, Hainer V, Basdevant A et al. Interdisciplinary European guidelines on surgery of severe obesity. Obes Facts., 2008; 1: 52-9.</mixed-citation><mixed-citation xml:lang="en">Fried M, Hainer V, Basdevant A et al. Interdisciplinary European guidelines on surgery of severe obesity. Obes Facts., 2008; 1: 52-9.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Bolen SD, Chang HY, Weiner JP, Richards TM, Shore AD, Goodwin SM, Johns RA, Magnuson TH, Clark JM. Clinical Outcomes after Bariatric Surgery: A Five-Year Matched Cohort Analysis in Seven US States. J Obes Surg., 2012. 1-21.</mixed-citation><mixed-citation xml:lang="en">Bolen SD, Chang HY, Weiner JP, Richards TM, Shore AD, Goodwin SM, Johns RA, Magnuson TH, Clark JM. Clinical Outcomes after Bariatric Surgery: A Five-Year Matched Cohort Analysis in Seven US States. J Obes Surg., 2012. 1-21.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
